Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

China Biologic Products Holdings Inc. (CBPO)

110.77   0.65 (0.59%) 05-29 16:00
Open: 109.68 Pre. Close: 110.12
High: 110.825 Low: 109.05
Volume: 90,143 Market Cap: 4,262M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 110.986 - 111.434 111.434 - 111.895
Low: 107.949 - 108.414 108.414 - 108.894
Close: 110.002 - 110.815 110.815 - 111.653

Technical analysis

as of: 2020-05-29 4:24:31 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 130.33     One year: 152.22
Support: Support1: 106.07    Support2: 102.67
Resistance: Resistance1: 111.58    Resistance2: 130.33
Pivot: 108.54
Moving Average: MA(5): 108.61     MA(20): 108.13
MA(100): 111.44     MA(250): 108.11
MACD: MACD(12,26): 0.50     Signal(9): 0.28
Stochastic oscillator: %K(14,3): 70.06     %D(3): 52.30
RSI: RSI(14): 57.94
52-week: High: 119.44  Low: 88.00  Change(%): 22.7
Average Vol(K): 3-Month: 12162  10-Days: 7133

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
CBPO has closed below upper band by 10.1%. Bollinger Bands are 5.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 12 May 2020
China Biologic Products to Report First Quarter 2020 Financial Results - Yahoo Finance

Thu, 21 May 2020
China Biologic Products Holdings, Inc. (CBPO) CEO Joseph Chow on Q1 2020 Results - Earnings Call Transcript - Seeking Alpha

Wed, 27 May 2020
Is China Biologic Products Holdings Inc (CBPO) Stock About to Get Hot Wednesday? - InvestorsObserver

Wed, 20 May 2020
China Biologic Reports Financial Results for the First Quarter of 2020 - PRNewswire

Wed, 20 May 2020
China Biologic Comments on the Xinjiang Deyuan and Shuanglin Transaction - PRNewswire

Thu, 07 May 2020
How Does Market View China Biologic Products Holdings Inc (CBPO) Stock's Recent Price & Volume Trends? - InvestorsObserver

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 38
Shares Float (M) 14
% Held by Insiders 54.17
% Held by Institutions 40.49
Shares Short (K) 425
Shares Short P. Month (K) 454

Stock Financials

EPS 3.950
EPS Est This Year 4.930
EPS Est Next Year 5.550
Book Value (p.s.) 45.110
Profit Margin 28.80
Operating Margin 35.00
Return on Assets (ttm) 5.8
Return on Equity (ttm) 9.8
Qtrly Rev. Growth 25.3
Gross Profit (p.s.) 8.556
Sales Per Share 13.951
EBITDA (p.s.) 5.571
Qtrly Earnings Growth 41.60
Operating Cash Flow (M) 273
Levered Free Cash Flow (M) 248

Stock Valuations

PE Ratio 28.04
PEG Ratio
Price to Book value 2.46
Price to Sales 7.94
Price to Cash Flow 15.61

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.